Brief report: Preventing HIV-1 infection in women using oral preexposure prophylaxis: A meta-analysis of current evidence

Journal of Acquired Immune Deficiency Syndromes

Volumn 73, Issue 5, 2016, Pages 606-608

  Hanscom, Brett ^a   Janes, Holly E ^a   Guarino, Peter D ^a   Huang, Ying ^a   Brown, Elizabeth R ^a   Chen, Ying Qing ^a   Hammer, Scott M ^b   Gilbert, Peter B ^a   Donnell, Deborah J ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

^b NewYork Presbyterian Hospital   (United States)

Author keywords

HIV prevention; pre exposure prophylaxis; PrEP; tenofovir; Truvada

Indexed keywords

EMTRICITABINE PLUS TENOFOVIR DISOPROXIL; ANTIRETROVIRUS AGENT; PLACEBO;

ARTICLE; CLINICAL EFFECTIVENESS; EAST AFRICAN; EPIDEMIC; FEMALE; GENITAL SYSTEM DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INFECTION PREVENTION; INFECTION RISK; INFLAMMATION; INTRAVENOUS DRUG ABUSE; MEDICATION COMPLIANCE; META ANALYSIS (TOPIC); MIXED INFECTION; PRE-EXPOSURE PROPHYLAXIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; RISK REDUCTION; VIRUS TRANSMISSION; AFRICA; HIV INFECTIONS; META ANALYSIS; PROCEDURES; TREATMENT OUTCOME;

AFRICA, SOUTHERN; ANTI-RETROVIRAL AGENTS; FEMALE; HIV INFECTIONS; HUMANS; MEDICATION ADHERENCE; PLACEBOS; PRE-EXPOSURE PROPHYLAXIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 84983022112     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0000000000001160     Document Type: Article

References (8)

1. World Health Organization. Guideline on When to Start Antiretroviral Therapy and on Pre-exposure Prophylaxis for HIV. Geneva, Switzerland: World Health Organisation; 2015. ISBN: 978 92 4 150956 5
2. Patterson KB, Prince HA, Kraft E, et al. Penetration of tenofovir and emtricitabine in mucosal tissues: implications for prevention of HIV-1 transmission. Sci Transl Med. 2011; 3: 112
3. Baeten JM, Donnell D, Ndase P, et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med. 2012; 367: 399-410
4. Thigpen MC, Kebaabetswe PM, Paxton LA, et al. Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. N Engl J Med. 2012; 367: 423-434
5. Choopanya K, Martin M, Suntharasamai P, et al. Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, doubleblind, placebo-controlled phase 3 trial. Lancet. 2013; 381: 2083-2090
6. Marrazzo JM, Ramjee G, Richardson BA, et al. Tenofovir-based preexposure prophylaxis for HIV infection among African women. N Engl J Med. 2015; 372: 509-518
7. Van Damme L, Corneli A, Ahmed K, et al. Preexposure prophylaxis for HIV infection among African women. N Engl J Med. 2012; 367: 411-422
8. Sutton AJ, Abrams KR, Jones DR, et al. Methods for Meta-analysis in Medical Research. Wiley Series in Probability and Statistics. Hoboken, New Jersey: John Wiley & Sons; 2000